Clinical Trial Update: Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sofosbuvir plus ribavirin in adults with recurrent chronic hepatitis C after liver transplantation reports safety and efficacy result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Recurrent Chronic Hepatitis C Virus, Post Liver Transplant | Phase 2 | Status: COMPLETED | Results posted: 2014-12-19